S.S.Healthcare

Yurpeak 2.5 mg/0.6ml Kwikpen is used to treat type II diabetes. Type II diabetes mellitus is a condition in which the body does not use insulin effectively, leading to abnormal blood glucose levels. Tirzepatide is also used in combination with other medicines to treat obesity.

Yurpeak 2.5 mg/0.6ml Kwikpen contains Tirzepatide, which works by increasing insulin levels in the body, thereby helping control blood sugar levels. It also helps reduce appetite by delaying stomach emptying and promotes feelings of fullness.

Afrezza 4IU Cartridge 30's is an insulin formulation designed to help manage blood sugar levels in individuals with type 1 and type 2 diabetes mellitus. It is commonly considered during insulin initiation, especially when evaluating the Afrezza starting dose 4IU, under medical supervision. Insulin plays a crucial role in helping glucose enter cells to be used as energy. Without adequate insulin action, sugar accumulates in the bloodstream, leading to long-term complications if left unmanaged.

Afrezza Powder for Inhalation(12 Unit Cartidges+1 Inhaler) is a short-acting insulin used to treat type 1 and type 2 diabetes mellitus. It is used together with a healthy diet and regular exercise to control blood sugar levels after meals. This helps to prevent serious complications of diabetes like kidney damage and blindness.

Yurpeak 15mg Kwikpen contains Tirzepatide as its active constituent. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists and is used primarily to manage blood sugar levels in adults with type 2 diabetes. This injectable medication helps improve glycemic control by mimicking the actions of natural incretin hormones. It enhances insulin secretion while reducing the release of glucagon, helping lower blood sugar after meals.

Afrezza 8IU Cartridge 30's is a fast-acting inhaled insulin used to control blood sugar levels around meals in people with type 1 and type 2 diabetes. It comes as Afrezza 8 unit green cartridges and is taken using a special inhaler, not an injection. Insulin helps sugar move from the blood into the body’s cells for energy. When insulin does not work properly, blood sugar levels can rise and cause health problems over time.

Yurpeak 5 mg/0.6ml Kwikpen is used to treat type II diabetes. Type II diabetes mellitus is a condition in which the body does not use insulin effectively, leading to abnormal blood glucose levels. Tirzepatide is also used in combination with other medicines to treat obesity.

Yurpeak 5 mg/0.6ml Kwikpen contains Tirzepatide, which works by increasing insulin levels in the body, thereby helping control blood sugar levels. It also helps reduce appetite by delaying stomach emptying and promotes feelings of fullness.

Yurpeak 7.5mg Kwikpen contains Tirzepatide as its active constituent. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists and is used primarily to manage blood sugar levels in adults with type 2 diabetes. This injectable medication helps improve glycemic control by mimicking the actions of natural incretin hormones. It enhances insulin secretion while reducing the release of glucagon, helping lower blood sugar after meals.

Yurpeak 10mg Kwikpen contains Tirzepatide as its active constituent. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists and is used primarily to manage blood sugar levels in adults with type 2 diabetes. This injectable medication helps improve glycemic control by mimicking the actions of natural incretin hormones. It enhances insulin secretion while reducing the release of glucagon, helping lower blood sugar after meals.

Yurpeak 12.5mg Kwikpen contains Tirzepatide as its active constituent. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists and is used primarily to manage blood sugar levels in adults with type 2 diabetes. This injectable medication helps improve glycemic control by mimicking the actions of natural incretin hormones. It enhances insulin secretion while reducing the release of glucagon, helping lower blood sugar after meals.